Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC - WACC | 694.0% | 1,539.7% | 1,527.3% | 575.0% | 1,727.9% | (2,292.9%) | (203.3%) | (226.2%) | (85.6%) | (108.7%) | (146.3%) | (207.7%) | (304.9%) | (339.2%) | (472.2%) | (176.5%) | (149.4%) | (143.8%) | (140.4%) | (205.5%) |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month ROIC - WACC is (200.7%), based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for Insmed Incorporated have been (161.6%) over the past three years, and (163.2%) over the past five years.
As of today, Insmed Incorporated's ROIC - WACC is (200.7%), which is lower than industry median of (132.6%). It indicates that Insmed Incorporated's ROIC - WACC is Bad.